Guidant CE-marks Galileo system for long lesions:
This article was originally published in Clinica
Executive Summary
Guidant has gained approval in Europe to expanded the market for its intravascular radiotherapy system for treating restenosis to include the treatment of longer coronary lesions. The Galileo system, first approved in Europe last year, has been CE-marked for sale as a treatment for long coronary lesions as long as 47mm.